AU9587198A - Immediate release drug delivery forms - Google Patents

Immediate release drug delivery forms

Info

Publication number
AU9587198A
AU9587198A AU95871/98A AU9587198A AU9587198A AU 9587198 A AU9587198 A AU 9587198A AU 95871/98 A AU95871/98 A AU 95871/98A AU 9587198 A AU9587198 A AU 9587198A AU 9587198 A AU9587198 A AU 9587198A
Authority
AU
Australia
Prior art keywords
drug delivery
immediate release
release drug
delivery forms
forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU95871/98A
Other languages
English (en)
Inventor
Hanan S. Anwar
Abhijit Banerjee
Deirdre M. Barrow
Claude Bayard
Beuford A. Bogue
Joseph Cascone
Steven E. Frisbee
Bernard M. Kiernan
Barry D. Mccarthy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biovail Technologies Ltd
Original Assignee
Fuisz Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/946,070 external-priority patent/US6013280A/en
Application filed by Fuisz Technologies Ltd filed Critical Fuisz Technologies Ltd
Publication of AU9587198A publication Critical patent/AU9587198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU95871/98A 1997-10-07 1998-09-28 Immediate release drug delivery forms Abandoned AU9587198A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/946,070 US6013280A (en) 1997-10-07 1997-10-07 Immediate release dosage forms containing microspheres
US08946070 1997-10-07
US12916498A 1998-08-05 1998-08-05
US09129164 1998-08-05
PCT/US1998/020266 WO1999017744A1 (en) 1997-10-07 1998-09-28 Immediate release drug delivery forms

Publications (1)

Publication Number Publication Date
AU9587198A true AU9587198A (en) 1999-04-27

Family

ID=26827301

Family Applications (1)

Application Number Title Priority Date Filing Date
AU95871/98A Abandoned AU9587198A (en) 1997-10-07 1998-09-28 Immediate release drug delivery forms

Country Status (7)

Country Link
EP (1) EP0966269A1 (de)
JP (1) JP2000507991A (de)
KR (1) KR20000069356A (de)
AU (1) AU9587198A (de)
BR (1) BR9806303A (de)
CA (1) CA2273272C (de)
WO (1) WO1999017744A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992018106A1 (en) * 1991-04-16 1992-10-29 Nippon Shinyaku Co., Ltd. Method of manufacturing solid dispersion
AU1323400A (en) * 1998-10-27 2000-05-15 Fuisz Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
IE981008A1 (en) * 1998-12-02 2000-06-14 Fuisz Internat Ltd Microparticles Containing Water Insoluble Active Agents
DZ3227A1 (fr) 1999-12-23 2001-07-05 Pfizer Prod Inc Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
US8980870B2 (en) * 2002-09-24 2015-03-17 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
US9149433B2 (en) * 2004-11-30 2015-10-06 Basf Corporation Method for formation of micro-prilled polymers
EP1897543A1 (de) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine-Waffel zur Substitutionstherapie
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1388786A (en) * 1972-04-03 1975-03-26 Scherer Corp R P Integral solid gel-lattice dosage form of high-moisture content
DE3927113C2 (de) * 1989-08-17 1993-11-25 Dolorgiet Gmbh & Co Kg Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
CA2095776C (en) * 1992-05-12 2007-07-10 Richard C. Fuisz Rapidly dispersable compositions containing polydextrose
CA2118517C (en) * 1992-06-10 2003-10-14 Gary G. Liversidge Surface modified nsaid nanoparticles
US5683720A (en) * 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
JPH11514979A (ja) * 1995-09-07 1999-12-21 フイズ テクノロジーズ リミテッド 実質的に非溶解性の生体作用薬剤をバイオ・アベイラブルにするシステム

Also Published As

Publication number Publication date
EP0966269A1 (de) 1999-12-29
JP2000507991A (ja) 2000-06-27
KR20000069356A (ko) 2000-11-25
WO1999017744A1 (en) 1999-04-15
CA2273272C (en) 2004-09-21
BR9806303A (pt) 2000-03-14
CA2273272A1 (en) 1999-04-15

Similar Documents

Publication Publication Date Title
AU5914999A (en) Controlled release drug delivery
PL344039A1 (en) Sustained release drug delivery devices
AU6140598A (en) Multipathway electronically-controlled drug delivery system
AU7493398A (en) Pulsatile drug delivery system
AU5335698A (en) Pharmaceutical formulations with delayed drug release
AU6876498A (en) Intravesical drug delivery system
AU1689599A (en) Sustained release medicinal compositions
AU3287699A (en) Ultrasound-mediated drug delivery
AU3904099A (en) Drug delivery module
AU6956398A (en) Implant delivery system
AU4400797A (en) Colon selective drug delivery composition
HUP0004945A3 (en) Delayed total release gastrointestinal drug delivery system
AU2827095A (en) Controlled release oral drug delivery system
AU5387898A (en) Pharmaceutical agents
EP1061987A4 (de) Vorrichtung zum verabreichen eines medikamentes
AU7711098A (en) Drug delivery system
AU1827799A (en) Oral delivery formulation
AU8374498A (en) Combination counter-ejector shingle-output delivery system
AU7201998A (en) Drug delivery system
AU3837999A (en) Drug delivery device
EP1021137A4 (de) Anordnung zur medikamentenzuführung
GB9714750D0 (en) Drug delivery device
AU9587198A (en) Immediate release drug delivery forms
AU2420997A (en) Oligopeptides for drug delivery
AU1671997A (en) Drug delivery system using galactoxyloglucan

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase